FAM153B
Protein FAM153B
Also known as: F153B_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for FAM153B in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
387 residues, UniProt reviewed canonical sequence.
>P0C7A2|FAM153B
1 MGCAYSCCLE VCCGEDEIVY PRMPGESTVC HREREKPITY HWYHWHPGHI YPRVASMEDY
61 DEDLVQEASS EDVLGVHMVD KDTERDIEMK RQLRRLRELH LYSTWKKYQE AMKTSLGVPQ
121 CERDEGSLGK PLCPPEILSE TLPGSVKKRV CFPSEDHLEE FIAEHLPEAS NQSLLTVAHA
181 DTGIQTNGDL EDLEEHGPGQ TVSEEATEVH MMEGDPDTLA ELLIRDVLQE LSSYNGEEED
241 PEEVKTSLGV PQRGDLEDLE EHVPGQTVSE EATGVHMMQV DPATPAKSDL EDLEEHVPGQ
301 TVSEEATGVH MMQVDPATLA KQLEDSTITG SHQQMSASPS SAPAEEATEK TKVEEEVKTR
361 KPKKKTRKPS KKSRWNVLKC WDIFNIFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM153B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.45
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM153B as an antibody target. Whether an autoantibody or antibody against FAM153B could matter depends on whether native FAM153B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM153B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM153B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...